000 02318na a2200253 4500
999 _c866
_d866
003 PC866
005 20210702062659.0
008 130622s2013 xxx||||| |||| 00| 0 eng d
040 _cH12O
041 _aspa
100 _91026
_aPulido Ortega, Federico
_eUnidad VIH
245 0 0 _aRecomendaciones de GESIDA/Secretaria del Plan Nacional sobre el Sida para el tratamiento de la tuberculosis en adultos infectados por el virus de la inmunodeficiencia humana (actualizacion enero de 2013).
_h[artículo]
260 _bEnfermedades infecciosas y microbiología clínica,
_c2013
300 _a31(10):672-84.
500 _aFormato Vancouver: Rivero A, Pulido F, Caylá J, Iribarren JA, Miró JM, Moreno S et al. Grupo de Estudio de Sida (GESIDA); Secretaría del Plan Nacional sobre el Sida. [The Spanish AIDS Study Group and Spanish National AIDS Plan (GESIDA/Secretaría del Plan Nacional sobre el Sida). Recomendaciones de GESIDA/Secretaria del Plan Nacional sobre el Sida para el tratamiento de la tuberculosis en adultos infectados por el virus de la inmunodeficiencia humana (actualizacion enero de 2013). Enferm Infecc Microbiol Clin. 2013 Dec;31(10):672-84.
501 _aPMID: 23541879
504 _aContiene 115 referencias
520 _aThis consensus document was prepared by an expert panel of the Grupo de Estudio de Sida (GESIDA [Spanish AIDS Study Group]) and the Plan Nacional sabre el Sida (PNS [Spanish National AIDS Plan]). The document updates current guidelines on the treatment of tuberculosis (TB) in HIV-infected individuals contained in the guidelines on the treatment of opportunistic infections published by GESIDA and PNS in 2008. The document aims to facilitate the management and treatment of HIV-infected patients with TB in Spain, and includes specific sections and recommendations on the treatment of drug-sensitive TB, multidrug-resistant TB, and extensively drug-resistant TB, in this population. The consensus guidelines also make recommendations on the treatment of HIV-infected patients with TB in special situations, such as chronic liver disease, pregnancy, kidney failure, and transplantation. Recommendations are made on the timing and initial regimens of antiretroviral therapy in patients with TB, and on immune reconstitution syndrome in HIV-infected patients with TB who are receiving antiretroviral therapy. The document does not cover the diagnosis of TB, diagnosis/treatment of latent TB, or treatment of TB in children. The quality of the evidence was evaluated and the recommendations graded using the approach of the Grading of Recommendations Assessment, Development and Evaluation Working Group.
710 _96
_aServicio de Medicina Interna
856 _uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/8/pc866.pdf
_ySolicitar documento
942 _n0
_2ddc
_cART